We are live on ! Find out more
BP

Banyan Partners Portfolio holdings

AUM $1.18B
1-Year Est. Return 16.95%
This Fund
S&P 500
This Quarter Est. Return
+4.99%
1 Year Est. Return
+16.95%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
+$23.4M
Cap. Flow
-$27.5M
Cap. Flow %
-2.32%
Top 10 Hldgs %
19.43%
Holding
424
New
35
Increased
145
Reduced
165
Closed
38

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$15.8M
2
MKL icon
Markel Group
MKL
+$10.4M
3
ESRX
Express Scripts Holding Company
ESRX
+$4.25M
4
CVS icon
CVS Health
CVS
+$3.28M
5
OXY icon
Occidental Petroleum
OXY
+$3.06M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$5.02M
2
CVX icon
Chevron
CVX
+$4.43M
3
AAPL icon
Apple
AAPL
+$4.25M
4
INTC icon
Intel
INTC
+$4.12M
5
GILD icon
Gilead Sciences
GILD
+$2.75M

Sector Composition

Rank Sector Weight
1 Financials 16.73%
2 Technology 15.88%
3 Healthcare 12.33%
4 Energy 11.12%
5 Industrials 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIG icon
26
American International
AIG
$42.5B
$11.3M 0.96%
207,827
-43,261
-17% -$2.29M
SBUX icon
27
Starbucks
SBUX
$118B
$11.1M 0.94%
287,644
+2,058
+0.7% +$74.8K
MKL icon
28
Markel Group
MKL
$24.8B
$10.8M 0.91%
+16,508
New +$10.4M
DD
29
DELISTED
Du Pont De Nemours E I
DD
$10.6M 0.9%
171,312
-4,822
-3% -$310K
ORCL icon
30
Oracle
ORCL
$354B
$10.5M 0.89%
259,980
-15,720
-6% -$647K
CELG
31
DELISTED
Celgene Corp
CELG
$10.5M 0.89%
122,092
-34,792
-22% -$2.65M
PFE icon
32
Pfizer
PFE
$142B
$9.92M 0.84%
352,265
+9,314
+3% +$266K
V icon
33
Visa
V
$688B
$9.72M 0.82%
184,512
-5,348
-3% -$280K
BLK icon
34
Blackrock
BLK
$165B
$9.15M 0.77%
28,623
-2,179
-7% -$668K
MMM icon
35
3M
MMM
$83.8B
$9.1M 0.77%
76,012
-4,388
-5% -$515K
PG icon
36
Procter & Gamble
PG
$347B
$8M 0.68%
101,749
-24,711
-20% -$1.99M
GILD icon
37
Gilead Sciences
GILD
$166B
$7.61M 0.64%
91,822
-35,375
-28% -$2.75M
PM icon
38
Philip Morris
PM
$300B
$7.61M 0.64%
90,227
-7,684
-8% -$662K
BAX icon
39
Baxter International
BAX
$11.5B
$7.53M 0.64%
191,619
+21,748
+13% +$870K
T icon
40
AT&T
T
$152B
$7.48M 0.63%
280,242
-1,810
-0.6% -$48.5K
CERN
41
DELISTED
Cerner Corp
CERN
$7.4M 0.63%
143,430
-6,629
-4% -$349K
ADT
42
DELISTED
ADT Corp
ADT
$7.29M 0.62%
208,545
+3,974
+2% +$127K
AFL icon
43
Aflac
AFL
$63.3B
$7.19M 0.61%
230,938
-39,460
-15% -$1.23M
ABBV icon
44
AbbVie
ABBV
$448B
$6.97M 0.59%
123,472
+33,864
+38% +$1.78M
CL icon
45
Colgate-Palmolive
CL
$73.3B
$6.86M 0.58%
100,607
-2,596
-3% -$174K
AMGN icon
46
Amgen
AMGN
$198B
$6.84M 0.58%
57,780
+7,697
+15% +$891K
BHI
47
DELISTED
Baker Hughes
BHI
$6.84M 0.58%
91,852
+35,469
+63% +$2.47M
CVS icon
48
CVS Health
CVS
$137B
$6.73M 0.57%
89,300
+43,378
+94% +$3.28M
TGT icon
49
Target
TGT
$63.6B
$6.63M 0.56%
114,443
+6,063
+6% +$357K
CMCSA icon
50
Comcast
CMCSA
$85.2B
$6.22M 0.53%
231,608
+64,556
+39% +$1.66M
1
2
3 4 5

Similar funds

MGC
Merchants' Gate Capital New York $1.27B AUM 15.57% 1-Year Est. Return
QLMGAA
QS Legg Mason Global Asset Allocation New York $1.04B AUM 9.55% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
NAM
Nexus Asset Management New York $725M AUM 12.9% 1-Year Est. Return
KFS
KMS Financial Services Seattle, Washington $713M AUM 14.21% 1-Year Est. Return
WIC
Wood Investment Counsel Denver, Colorado $669M AUM 20.44% 1-Year Est. Return
MWR
McAdams Wright Ragen Seattle, Washington $1.79B AUM 13.95% 1-Year Est. Return
CHFS
Cobble Hill Financial Services Moorestown, New Jersey $541M AUM 8.99% 1-Year Est. Return

Banyan Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Banyan Partners held 424 positions worth $1.18B, up 2% from $1.16B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Banyan Partners's Q2 2014 filing shows 35 new, 145 increased, 165 reduced and 38 closed positions. Its largest new stake was Berkshire Hathaway Class A: 83 shares worth $15.8M. The largest sale was Allergan Inc, an estimated $5.02M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • Banyan Partners's largest Q2 2014 buy was Berkshire Hathaway Class A: 83 shares worth $15.8M.
  • Banyan Partners added most to Express Scripts Holding Company in Q2 2014, an estimated $4.25M increase.
  • Banyan Partners's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $5.02M.
  • Banyan Partners fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $2.15M.
  • Banyan Partners's ten largest holdings make up 19% of its $1.18B portfolio in Q2 2014.
  • Banyan Partners opened 35 new positions and closed 38 in Q2 2014.
  • Banyan Partners's portfolio value rose 2% quarter-over-quarter to $1.18B.

Based on Banyan Partners's 13F filing for Q2 2014, filed 8 Aug 2014.